Search hospitals > New York > New York
NYU School of Medicine's Kaplan Comprehensive Cancer Center
Claim this profileNew York, New York 10016
Global Leader in Breast Cancer
Global Leader in Ovarian Cancer
Conducts research for Brain Tumor
Conducts research for Lymphoma
Conducts research for Lung Cancer
273 reported clinical trials
6 medical researchers
Summary
NYU School of Medicine's Kaplan Comprehensive Cancer Center is a medical facility located in New York, New York. This center is recognized for care of Breast Cancer, Ovarian Cancer, Brain Tumor, Lymphoma, Lung Cancer and other specialties. NYU School of Medicine's Kaplan Comprehensive Cancer Center is involved with conducting 273 clinical trials across 223 conditions. There are 6 research doctors associated with this hospital, such as Paul Oberstein, MD, Janice M. Mehnert, Kristen Spencer, MD, and Elaine Shum, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
Stage IV
PR positive
2Ovarian Cancer
Global LeaderStage III
Stage IV
HER2 positive
Top PIs
Paul Oberstein, MDNYU Langone Health4 years of reported clinical research
Expert in Pancreatic Cancer
Studies Colorectal Cancer
21 reported clinical trials
49 drugs studied
Janice M. MehnertLaura and Isaac Perlmutter Cancer Center at NYU Langone5 years of reported clinical research
Expert in Melanoma
Studies Cancer
18 reported clinical trials
26 drugs studied
Kristen Spencer, MDRutgers Cancer Institute of New Jersey3 years of reported clinical research
Studies Cancer
Studies Pancreatic Cancer
14 reported clinical trials
46 drugs studied
Elaine Shum, MDNYU Langone Health5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
17 drugs studied
Clinical Trials running at NYU School of Medicine's Kaplan Comprehensive Cancer Center
Lung Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Breast Cancer
Cancer
Microsatellite Instability
Bladder Cancer
Pancreatic Cancer
Usher syndrome
Small Cell Lung Cancer
REGN5093
for Lung Cancer
This study will evaluate REGN5093 for the treatment of Non-Small Cell Lung Cancer (NSCLC) with MET alteration. The main purpose of this study is to determine the safety, tolerability, and effectiveness of REGN5093. The study has two phases. The main goal of Phase 1 is to determine a safe dose(s) of REGN5093. The main goal of phase 2 of the study is to use the REGN5093 drug dose(s) found in Phase 1 to see how well REGN5093 works to shrink tumors. The study is looking at several other research questions, including: * Side effects that may be experienced by people taking REGN5093 * How REGN5093 works in the body * How much REGN5093 is present in the blood * To see if REGN5093 works to reduce or delay the progression of cancer * How long it takes REGN5093 to work in the body
Recruiting1 award Phase 1 & 25 criteria
Biomarker Screening
for Lung Cancer
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
Recruiting1 award N/A10 criteria
Divarasib + Pembrolizumab
for Non-Small Cell Lung Cancer
This trial is testing a new drug called divarasib along with other cancer treatments. It focuses on people with advanced or metastatic non-small cell lung cancer. The study aims to see how divarasib moves through the body, its safety, and if it helps fight the cancer.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at NYU School of Medicine's Kaplan Comprehensive Cancer Center?
NYU School of Medicine's Kaplan Comprehensive Cancer Center is a medical facility located in New York, New York. This center is recognized for care of Breast Cancer, Ovarian Cancer, Brain Tumor, Lymphoma, Lung Cancer and other specialties. NYU School of Medicine's Kaplan Comprehensive Cancer Center is involved with conducting 273 clinical trials across 223 conditions. There are 6 research doctors associated with this hospital, such as Paul Oberstein, MD, Janice M. Mehnert, Kristen Spencer, MD, and Elaine Shum, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.